title: Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB.
abstract: Although cyclophilin A (CypA) has been reported to be over-expressed in cancer cells and solid tumors, its expression and role in glioblastomas have not been studied. Herein, we show that expression of CypA in human glioblastoma cell lines and tissues is significantly higher than in normal human astrocytes and normal counterparts of brain tissue. To determine the role of over-expressed CypA in glioblastoma, stable RNA interference (RNAi)-mediated knockdown of CypA (CypA KD) was performed in gliobastoma cell line U87vIII (U87MG · ΔEGFR). CypA KD stable single clones decrease proliferation, infiltration, migration, and anchorage-independent growth in vitro and with slower growth in vivo as xenografts in immunodeficient nude mice. We have also observed that knockdown of CypA inhibits expression of interleukin-8 (IL-8), a tumorigenic and proangiogenic cytokine. Conversely, enforced expression of CypA in the CypA KD cell line, Ud-12, markedly enhanced IL-8 transcripts and restored Ud-12 proliferation, suggesting that CypA-mediated IL-8 production provides a growth advantage to glioblastoma cells. CypA knockdown-mediated inhibition of IL-8 is due to reduced activity of NF-κB, which is one of the major transcription factors regulating IL-8 expression. These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.
authors.affiliation: Dental Research Institute, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.
authors.forename: Shan
authors.initials: S
authors.lastname: Sun
authors.forename: Qiuwei
authors.initials: Q
authors.lastname: Wang
authors.forename: An
authors.initials: A
authors.lastname: Giang
authors.forename: Cong
authors.initials: C
authors.lastname: Cheng
authors.forename: Chia
authors.initials: C
authors.lastname: Soo
authors.forename: Cun-Yu
authors.initials: CY
authors.lastname: Wang
authors.forename: Linda M
authors.initials: LM
authors.lastname: Liau
authors.forename: Robert
authors.initials: R
authors.lastname: Chiu
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D021984:Cyclophilin A / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D024202:Electrophoretic Mobility Shift Assay; D004797:Enzyme-Linked Immunosorbent Assay; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D016209:Interleukin-8 / Q000378:metabolism*; D051379:Mice; D008819:Mice, Nude; D016328:NF-kappa B / Q000378:metabolism*; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D046888:Tissue Array Analysis
chemical_list: D016209:Interleukin-8; D016328:NF-kappa B; D021984:Cyclophilin A
references.citation: Nat Chem Biol. 2007 Oct;3(10):619-29
references.pmid: 17876319
references.citation: Neurochem Int. 2005 Nov;47(6):430-41
references.pmid: 16087277
references.citation: Lung Cancer. 1997 Oct;18(2):189-98
references.pmid: 9316010
references.citation: Cancer Res. 2004 Dec 15;64(24):9018-26
references.pmid: 15604267
references.citation: J Immunol. 2005 Jul 1;175(1):517-22
references.pmid: 15972687
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):1810-23
references.pmid: 18421009
references.citation: J Exp Med. 2007 Aug 6;204(8):1741-8
references.pmid: 17635954
references.citation: Cancer Res. 2007 Apr 15;67(8):3654-62
references.pmid: 17440077
references.citation: J Biol Chem. 2004 Jun 4;279(23):24414-9
references.pmid: 15047706
references.citation: Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1186-91
references.pmid: 15130913
references.citation: Rev Physiol Biochem Pharmacol. 2003;148:105-50
references.pmid: 12698322
references.citation: Oncogene. 2009 Aug 6;28(31):2784-95
references.pmid: 19503092
references.citation: Cancer Chemother Pharmacol. 2008 Mar;61(3):459-69
references.pmid: 17520256
references.citation: Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193-7
references.pmid: 8234276
references.citation: J Cell Biochem. 2008 Aug 1;104(5):1625-35
references.pmid: 18320592
references.citation: Eur Cytokine Netw. 1993 Sep-Oct;4(5):351-8
references.pmid: 8117936
references.citation: Immunity. 2004 Aug;21(2):189-201
references.pmid: 15308100
references.citation: Lung Cancer. 2004 Dec;46(3):313-23
references.pmid: 15541816
references.citation: Nat Cell Biol. 2004 Feb;6(2):97-105
references.pmid: 14743216
references.citation: Cancer Res. 2003 Apr 1;63(7):1652-6
references.pmid: 12670919
references.citation: Brain. 2007 Feb;130(Pt 2):476-89
references.pmid: 17107968
references.citation: Neuro Oncol. 2005 Apr;7(2):122-33
references.pmid: 15831231
references.citation: J Leukoc Biol. 2002 Nov;72(5):847-55
references.pmid: 12429706
references.citation: Oncogene. 2004 Sep 9;23(41):6924-32
references.pmid: 15286717
references.citation: J Biol Chem. 2008 Jan 4;283(1):623-637
references.pmid: 17991743
references.citation: J Neurooncol. 1993 Apr;16(1):25-34
references.pmid: 8410139
references.citation: Biochem Biophys Res Commun. 2002 Mar 8;291(4):1031-7
references.pmid: 11866469
references.citation: J Biol Chem. 1995 Feb 10;270(6):2588-94
references.pmid: 7852322
references.citation: Clin Immunol. 2005 Sep;116(3):217-24
references.pmid: 15993649
references.citation: Science. 1984 Nov 2;226(4674):544-7
references.pmid: 6238408
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: J Immunol. 2005 May 15;174(10):6030-8
references.pmid: 15879096
references.citation: Oncogene. 1999 Feb 18;18(7):1447-56
references.pmid: 10050881
references.citation: Mol Cell Biol. 1993 Aug;13(8):4760-9
references.pmid: 7687744
references.citation: Cancer Res. 2005 Oct 1;65(19):8853-60
references.pmid: 16204056
references.citation: Curr Opin Oncol. 2001 May;13(3):160-6
references.pmid: 11307058
references.citation: Immunology. 1991 Mar;72(3):399-404
references.pmid: 2026447